Table 2 Genotype distribution patterns and allelic frequencies of Dvl polymorphisms among patients with MDD and control subjects.
SNP | Sample | Genotype (%) | P | Allele (%) | P | Odds ratio (95% CI) | |||
|---|---|---|---|---|---|---|---|---|---|
rs1969253 | CC | CA | AA | C | A | ||||
MDD | 123 (22.4) | 302 (54.9) | 125 (22.7) | 0.056 | 548 (49.8) | 552 (50.2) | 0.055 | 1.177 | |
Control | 162 (29.3) | 271 (49.1) | 119 (21.6) | 595 (53.9) | 509 (46.1) | (0.996–1.392) | |||
rs1709642 | CC | CT | TT | C | T | ||||
MDD | 107 (19.5) | 313 (56.9) | 130 (23.6) | 1.19E-04 | 527 (47.9) | 573 (52.1) | 0.002 | 1.333 | |
Control | 171 (31.0) | 266 (48.2) | 115 (20.8) | 608 (55.1) | 496 (44.9) | (1.127–1.576) | |||
